Administrative Instructions under the Patent Cooperation Treaty
Annex C, Appendix 2
Nucleotide and Amino Acid Symbols and Feature Table
Table 2: List of Modified Nucleotides
|
Symbol
|
Meaning
|
|---|---|
|
ac4c |
4-acetylcytidine
|
| chm5u |
5-(carboxyhydroxymethyl)uridine
|
|
cm
|
2’-O-methylcytidine
|
| cmnm5s2u |
5-carboxymethylaminomethyl-2-thiouridine
|
|
cmnm5u
|
5-carboxymethylaminomethyluridine
|
| d |
dihydrouridine
|
|
fm
|
2’-O-methylpseudouridine
|
|
gal q
|
beta, D-galactosylqueuosine
|
|
gm
|
2’-O-methylguanosine
|
| i |
inosine
|
|
i6a
|
N6-isopentenyladenosine
|
|
m1a
|
1-methyladenosine
|
|
m1f
|
1-methylpseudouridine
|
|
m1g
|
1-methylguanosine
|
|
m1i
|
1-methylinosine
|
|
m22g
|
2,2-dimethylguanosine
|
|
m2a
|
2-methyladenosine
|
|
m2g
|
2-methylguanosine
|
|
m3c
|
3-methylcytidine
|
|
m5c
|
5-methylcytidine
|
|
m6a
|
N6-methyladenosine
|
|
m7g
|
7-methylguanosine
|
|
mam5u
|
5-methylaminomethyluridine
|
|
mam5s2u
|
5-methoxyaminomethyl-2-thiouridine
|
|
man q
|
beta, D-mannosylqueuosine
|
|
mcm5s2u
|
5-methoxycarbonylmethyl-2-thiouridine
|
|
mcm5u
|
5-methoxycarbonylmethyluridine
|
|
mo5u
|
5-methoxyuridine
|
|
ms2i6a
|
2-methylthio-N6-isopentenyladenosine
|
|
ms2t6a
|
N-((9-beta-D-ribofuranosyl-2-methylthiopurine-6-yl)carbamoyl)threonine
|
|
mt6a
|
N-((9-beta-D-ribofuranosylpurine-6-yl)N-methylcarbamoyl)threonine
|
|
mv
|
uridine-5-oxyacetic acid-methylester
|
|
o5u
|
uridine-5-oxyacetic acid
|
|
osyw
|
wybutoxosine
|
| p |
pseudouridine
|
| q |
queuosine
|
|
s2c
|
2-thiocytidine
|
|
s2t
|
5-methyl-2-thiouridine
|
|
s2u
|
2-thiouridine
|
|
s4u
|
4-thiouridine
|
| t |
5-methyluridine
|
|
t6a
|
N-((9-beta-D-ribofuranosylpurine-6-yl)-carbamoyl)threonine
|
| tm |
2’-O-methyl-5-methyluridine
|
| um |
2’-O-methyluridine
|
| yw |
wybutosine
|
| x |
3-(3-amino-3-carboxy-propyl)uridine, (acp3)u
|
|
|
